111 (NASDAQ:YI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the quarter, Zacks reports. The business had revenue of $486.35 million during the quarter.
111 Trading Down 2.0%
Shares of NASDAQ YI opened at $7.75 on Friday. The business has a 50-day moving average of $7.99 and a 200-day moving average of $7.57. 111 has a 12 month low of $4.15 and a 12 month high of $12.90. The firm has a market capitalization of $66.97 million, a price-to-earnings ratio of -12.11 and a beta of 0.47.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 111 in a research note on Wednesday, June 11th.
111 Company Profile
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Read More
- Five stocks we like better than 111
- The Role Economic Reports Play in a Successful Investment Strategy
- These 3 Consumer Staple Giants Are Oversold and Set to Skyrocket
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- MarketBeat Week in Review – 06/16 – 06/20
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
